Inventor · disambiguated record
Esteban Celis
Also filed as: CELIS ESTEBAN
21 granted patents·29 pending applications·1,036 citations·filing 1993–2022
96Inventor score
Top patents by PatentIndex Score
50 records- 0197US6037135AMethods for making HLA binding peptides and their usesEPIMMUNE INC·Filed 1993·Granted Mar 14, 2000·308 cites·68 claims
- 0296US7026443B1Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2000·Granted Apr 11, 2006·92 cites·10 claims
- 0396US6602510B1HLA class I A2 tumor associated antigen peptides and vaccine compositionsEPIMMUNE INC·Filed 2000·Granted Aug 5, 2003·94 cites·11 claims
- 0495US5662907AInduction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopesCYTEL CORP·Filed 1994·Granted Sep 2, 1997·187 cites·23 claims
- 0590US6419931B1Compositions and methods for eliciting CTL immunityEPIMMUNE INC·Filed 1994·Granted Jul 16, 2002·94 cites·27 claims
- 0688US8263560B2HPV 16 peptide vaccine for head and neck cancerSTROME SCOTT E·Filed 2007·Granted Sep 11, 2012·4 cites·15 claims
- 0787US9340577B2HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2004·Granted May 17, 2016·21 cites·6 claims
- 0886US5846827AMethods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTLCYTEL CORP·Filed 1995·Granted Dec 8, 1998·114 cites·16 claims
- 0984US6689363B1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 1999·Granted Feb 10, 2004·69 cites·55 claims
- 1083US7572882B2Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2000·Granted Aug 11, 2009·6 cites·13 claims
- 1182US11041011B2Human alpha fetoprotein-specific murine T cell receptors and uses thereofUNIV RES INST INC AUGUSTA·Filed 2018·Granted Jun 22, 2021·1 cites·3 claims
- 1279US7842480B2Chimeric antigen-specific t cell-activating polypeptidesMAYO FOUNDATION·Filed 2002·Granted Nov 30, 2010·7 cites·20 claims
- 1372US8822182B2Chimeric antigen-specific T cell-activating polypeptidesCELIS ESTEBAN·Filed 2010·Granted Sep 2, 2014·1 cites·7 claims
- 1472US7611713B2Inducing cellular immune responses to hepatitis B virus using peptide compositionsPHARMEXA INC·Filed 2003·Granted Nov 3, 2009·5 cites·5 claims
- 1571US7252829B1HLA binding peptides and their usesIDM PHARMA INC·Filed 1998·Granted Aug 7, 2007·30 cites·3 claims
- 1668US12173045B2Human alpha fetoprotein-specific t cell receptors and uses thereofUNIV RES INST INC AUGUSTA·Filed 2021·Granted Dec 24, 2024·0 cites·5 claims
- 1766US9770513B2Method of developing a vaccine using peptide-poly IC complexesH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Sep 26, 2017·0 cites·13 claims
- 1866US7795381B2Methods and materials for cancer treatmentMAYO FOUNDATION·Filed 2008·Granted Sep 14, 2010·0 cites·4 claims
- 1966US2009012004A1HLA binding peptides and their usesIDM PHARMA INC·Filed 2007·Application pending·0 cites
- 2065US2009214632A1Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2008·Application pending·0 cites
- 2164US2008279924A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2007·Application pending·0 cites
- 2261US10463747B2Method of developing a vaccine using peptide-poly IC complexesH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Nov 5, 2019·0 cites·13 claims
- 2361US2011070252A1Mage-a3/hpv 16 peptide vaccines for head and neck cancerMAYO FOUNDATION·Filed 2010·Application pending·0 cites
- 2460US2007098776A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2006·Application pending·0 cites
- 2560US2006222656A1MAGE-A3/HPV 16 peptide vaccines for head and neck cancerUNIV MARYLAND·Filed 2006·Application pending·0 cites
- 2659US7422751B2Epstein-barr-virus-specific immunizationMAYO FOUNDATION·Filed 2003·Granted Sep 9, 2008·0 cites·8 claims
- 2759US2010068228A1Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid CompositionsPHARMEXA INC·Filed 2009·Application pending·0 cites
- 2856US2025090647A1Optimized multidimensional biological activity of poly-iclc with controlled component size and formulationONCOVIR INC·Filed 2022·Application pending·0 cites
- 2955US2010183646A1Mage-a3/hpv 16 peptide vaccines for head and neck cancerUNIV MARYLAND·Filed 2010·Application pending·0 cites
- 3054US2011318408A1Hla class i a2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2011·Application pending·0 cites
- 3154US2008260762A1HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2007·Application pending·0 cites
- 3253US2003099634A1Compositions and methods for eliciting CTL immunityFiled 2002·Application pending·0 cites
- 3351US2013017253A1Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid CompositionsSETTE ALESSANDRO·Filed 2012·Application pending·0 cites
- 3449US2005196403A1Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsFiled 2005·Application pending·0 cites
- 3549US2005271676A1Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 3648US2004202654A1Methods and materials for cancer treatmentMAYO FOUNDATION·Filed 2002·Application pending·0 cites
- 3748US2011097352A9Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 3848US2016193316A1Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid CompositionsEPIMMUNE INC·Filed 2015·Application pending·0 cites
- 3946US2009304746A1Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 4045US2004053822A1Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4145US2004146519A1Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4244US2007059799A1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2006·Application pending·0 cites
- 4344US2007020327A1Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsFIKES JOHN·Filed 2006·Application pending·0 cites
- 4443US2004048790A1Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4543US2014147490A1Hla class i a2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2012·Application pending·0 cites
- 4643US2004121946A9Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4742US2003224036A1Hla class I a2 tumor associated antigen peptides and vaccine compositionsFiled 2000·Application pending·0 cites
- 4842US2004037843A1Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4936US9266930B1Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositionsSETTE ALESSANDRO·Filed 1999·Granted Feb 23, 2016·3 cites·4 claims
- 5029US2002168374A1Hla binding peptides and their usesFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Esteban Celis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →